Phosphorylated tau 181

There are 147 papers on phosphorylated tau 181 in aging research: 5 trials and 134 observational studies in people, 3 in animals, 5 reviews. The newest story, Oct 19, 2026: “Nerve-cell injury marker linked to death risk at ages 92–107”.

Biomarker

147 papers study it65 more mention it52 findings

6 new papers in 30 daysSee all 212 papers on phosphorylated tau 181

At a glance

Higher phosphorylated tau 181 is linked with Alzheimer's disease risk and worse cognitive function in human observational studies. Other cohorts show no clear cognitive link, including cognitively unimpaired older adults without subjective cognitive decline. Higher plasma levels are also linked with slower gait, while a memory-clinic cohort shows no clear link with physical function.

52 findings in 45 papers from 2021 to 2026, 8 of them since April 2026

“There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”
Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adultsScientific reports2023doi:10.1038/s41598-023-30167-0
  • Human trial5
  • Humans134
  • Animals3

Interventions

5

Processing delay

no changein humans1upin humans1

1 study
  1. Processing delay was not clearly linked with phosphorylated tau 181 in humans.

    “Plasma p-tau-181 levels notably increased with a 24-, 48-, and 72-h processing delay, but remained stable in serum.”

    HumansSerum24, 48, and 72 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

  2. Processing delay is linked with higher phosphorylated tau 181 in humans.

    “Plasma p-tau-181 levels notably increased with a 24-, 48-, and 72-h processing delay, but remained stable in serum.”

    HumansPlasma24, 48, and 72 hoursn = 41

    Pre-Analytical Variables Influencing Stability of Blood-Based Biomarkers of Neuropathology

    Journal of Alzheimer's disease : JAD

More on Processing delay

Neighborhood disadvantage

no changein humans1

1 study
  1. Neighborhood disadvantage was not clearly linked with phosphorylated tau 181 in humans.

    “pTau-181 was not associated with ADI for any group.”

    Humans

    Associations between Alzheimer's disease blood biomarkers and neighborhood disadvantage: A HABS-HD community cohort study

    Journal of Alzheimer's disease : JAD

More on Neighborhood disadvantage

Rapamycin

upin humans1

1 study
  1. Rapamycin increases phosphorylated tau 181 in CSF of people with mild cognitive impairment or dementia (therapeutic trial).

    “participants in the therapeutic trial displayed increased plasma cytokines and CSF phosphorylated tau 181, neurofilament light, and glial fibrillary acidic protein levels”

    Human trialin CSF of people with mild cognitive impairment or dementia (therapeutic trial)1 mg/day4-12 weeks

    Stage-Dependent Effects of Rapamycin for Alzheimer’s Disease: Insights from Prevention and Treatment Trials

    GSA 2025 abstract

More on Rapamycin

DPP-4 inhibitors

downin humans1

1 study
  1. DPP-4 inhibitors are linked with lower phosphorylated tau 181 in older adults with type 2 diabetes (β = -0.39, P < 0.05).

    “Multiple regression analyses revealed a significant negative association between DPP‐4 inhibitor use and p ‐tau 181 changes across all models (Model 1, β = ‐0.35; Model 2, β = ‐0.35; Model 3, β = ‐0.42; Model 4, β = ‐0.39; all P < 0.05).”

    Humansin older adults with type 2 diabetesplasma18 monthsn = 43

    Association between DPP‐4 inhibitor use and changes in dementia‐related plasma biomarkers in older adults with type 2 diabetes: post‐hoc analyses of J‐MINT

    AAIC 2025 abstract

More on DPP-4 inhibitors

Camellia sinensis

downin humans1

1 study
  1. Camellia sinensis is linked with lower phosphorylated tau 181 in humans (P < 0.000).

    “serum pTau181 (P < 0.000), Aβ42 (P = 0.019) and total Aβ levels (P = 0.034) but not serum Aβ40 levels, were lower in the tea-consuming group”

    Humansserumn = 264

    Green tea improves cognitive function through reducing AD-pathology and improving anti-oxidative stress capacity in Chinese middle-aged and elderly people

    Frontiers in aging neuroscience

More on Camellia sinensis

Effects

5

Cognitive function

no changein humans2downin humans1

3 studies
  1. Phosphorylated tau 181 is linked with worse cognitive function in humans (overall).

    “Overall, P-tau181 was significantly associated with vascular risk factors and inversely associated with cognitive function.”

    Humansoverall

    Plasma phosphorylated tau 181, vascular risk factors, and cognition in elderly Hispanics

    Journal of Alzheimer's disease : JAD

  2. Phosphorylated tau 181 was not clearly linked with cognitive function in humans.

    “we did not observe any significant relationships between plasma p-tau 181 and cognition”

    Humansn = 738

    Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults

    Neurobiology of aging

  3. Phosphorylated tau 181 was not clearly linked with cognitive function in humans (cognitively unimpaired older adults without subjective cognitive decline).

    “Finally, baseline pTau was not associated with any cognitive measure at baseline or follow-up.”

    Humanscognitively unimpaired older adults without subjective cognitive declinen = 230

    White matter lesions may be an early marker for age-related cognitive decline

    NeuroImage. Clinical

Vessel skeleton density

no changein humans1

1 study
  1. Phosphorylated tau 181 was not clearly linked with vessel skeleton density in humans.

    “Our study found no significant association between either GFAP or pTau181 and VSD.”

    Humans

    Association of ADRD Biomarkers and Vessel Skeleton Density (VSD) Derived from Optical Coherence Tomography Angiography (OCTA)

    AAIC 2025 abstract

More on Vessel skeleton density

Gait velocity

downin humans1

1 study
  1. Phosphorylated tau 181 is linked with worse gait velocity in humans (adjusted for age, sex, BMI, Charlson Comorbidity Index, and cognitive diagnosis) (-2.617 cm/sec per SD (95% CI: -3.414, -1.819)).

    “and 2.617 (-3.414, -1.819; p = 1.5 × 10−10) cm/sec, respectively.”

    Humansadjusted for age, sex, BMI, Charlson Comorbidity Index, and cognitive diagnosisplasman = 2,641

    Association of plasma biomarkers of Alzheimer's pathology and neurodegeneration with gait performance in older adults

    Communications medicine

Cognitive screening test performance

no changein humans1

1 study
  1. Phosphorylated tau 181 was not clearly linked with cognitive screening test performance in humans (Associations with CSID and AQ scores in Congolese individuals).

    “However, p-tau 181 did not exhibit significant associations with either measure.”

    HumansAssociations with CSID and AQ scores in Congolese individualsn = 81

    The Association of Alzheimer's Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa

    medRxiv : the preprint server for health sciencesPreprint

Physical function

no changein humans1

1 study
  1. Phosphorylated tau 181 was not clearly linked with physical function in humans (memory clinic cohort).

    “P-tau181 was not associated with any of the mobility outcomes in any of the analyses.”

    Humansmemory clinic cohortn = 64

    Mobility and associations with levels of cerebrospinal fluid amyloid β and tau in a memory clinic cohort

    Frontiers in aging neuroscience

Upstream

4

APOE

upin humans1

1 study
  1. APOE is linked with higher phosphorylated tau 181 in Hispanics/Latinos.

    “ε4 was associated with lower Aβ42/40 and higher p-tau181and GFAP levels”

    Humansin Hispanics/Latinos

    APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on APOE

Hearing loss

no changein humans1

1 study
  1. Hearing loss was not clearly linked with phosphorylated tau 181 in humans.

    “audiometric hearing was not correlated with AD‐specific biomarkers (Ab42/40 ratio, p ‐tau181)”

    Humans

    Audiometric hearing and plasma biomarkers of Alzheimer's disease pathology and neurodegeneration in the Atherosclerosis Risk in Communities Neurocognitive Study

    AAIC 2025 abstract

Inflammation

upin humans1

1 study
  1. Inflammation is linked with higher phosphorylated tau 181 in dementia-free older adults.

    “Systemic inflammation amplified the associations between several chronic diseases and p-tau181, t-tau, NfL, and GFAP.”

    Humansin dementia-free older adults

    Blood biomarkers of Alzheimer's disease in the community: Variation by chronic diseases and inflammatory status

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Inflammation

Modifiable dementia risk factors

no changein humans1

1 study
  1. modifiable dementia risk factors were not clearly linked with phosphorylated tau 181 in humans.

    “Modifiable dementia risk factors were not associated with plasma p-tau 181”

    Humansn = 738

    Modifiable risk factors for dementia, cognition, and plasma phosphorylated tau 181 in a large-scale cohort of Australian older adults

    Neurobiology of aging

Associations

35

LRRTM4

mixedin humans1

1 study
  1. LRRTM4 is associated with phosphorylated tau 181 in humans (Midwestern Amish cohort).

    “Additionally, novel candidate genes were implicated, including MME for A{beta}42/A{beta}40 ratio, and VEGFC and LRRTM4 for p-tau181.”

    HumansMidwestern Amish cohortplasma

    Genetic Architecture of Plasma Amyloid and Tau Biomarkers in the Amish

    medRxivPreprint

More on LRRTM4

VEGFC

mixedin humans1

1 study
  1. VEGFC is associated with phosphorylated tau 181 in humans (Midwestern Amish cohort).

    “Additionally, novel candidate genes were implicated, including MME for A{beta}42/A{beta}40 ratio, and VEGFC and LRRTM4 for p-tau181.”

    HumansMidwestern Amish cohortplasma

    Genetic Architecture of Plasma Amyloid and Tau Biomarkers in the Amish

    medRxivPreprint

More on VEGFC

Estrone

downin humans1

1 study
  1. Estrone is associated with phosphorylated tau 181 in humans (exploratory longitudinal analysis).

    “In exploratory longitudinal analyses, estrone showed a modest association with slower pTau181 increase.”

    Humansexploratory longitudinal analysisfemalesn = 187

    Associations between serum estradiol and estrone and Alzheimer's disease biomarkers: An analysis in female participants from the European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS)

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Estrone

Cognitive impairment

upin humans1

1 study
  1. Phosphorylated tau 181 is associated with cognitive impairment in humans (Postmenopausal women with insomnia disorder; non-CI n=42 and CI n=37) (1,002.18 vs. 918.27 pg/mL in CI versus non-CI).

    “the CI group had higher plasma GFAP (14.82 vs. 12.42 ng/mL, P = .004) and p-Tau (1,002.18 vs. 918.27 pg/mL, P = .034).”

    HumansPostmenopausal women with insomnia disorder; non-CI n=42 and CI n=37females

    Plasma Biomarkers Differentiate Cognitive Impairment in Postmenopausal Women with Insomnia Disorder

    Psychiatry and clinical psychopharmacology

More on Cognitive impairment

Social isolation

upin humans1

1 study
  1. Social isolation is associated with phosphorylated tau 181 in humans (Resolving moderate-to-severe social isolation) (β 0.11).

    “resolving moderate-to-severe social isolation and, for men, persistent severe social isolation were each associated with higher p-tau181 ( β resolving : 0.11;”

    HumansResolving moderate-to-severe social isolationserumn = 3,862

    Social isolation linked to blood marker of nerve-cell injury

    medRxiv : the preprint server for health sciencesPreprint

More on Social isolation

Allantoin

upin humans1

1 study
  1. Allantoin is associated with phosphorylated tau 181 in humans (cognitively normal older adults) (r = 0.47, pFDR < 0.01).

    “positive correlations between allantoin, and NFL (r = 0.40, pFDR < 0.01), pTau181 (r = 0.47, pFDR < 0.01)”

    Humanscognitively normal older adults

    The Relationship between Ergothioneine, Allantoin and Neocortical Amyloid Load

    Aging and disease

More on Allantoin

Cognitive function

downin humans1

1 study
  1. Phosphorylated tau 181 is associated with cognitive function in humans (outpatients) (β = -0.19, p = 0.020).

    “P-tau181 was directly associated to cognitive performance (β = -0.19, p = 0.020)”

    Humansoutpatientsplasman = 206

    Blood neurodegeneration biomarkers and the muscle-brain axis in older adults: physical performance as a functional mediator of cognition

    Experimental gerontology

IGFBP-2

mixedin humans1

1 study
  1. IGFBP-2 is associated with phosphorylated tau 181 in humans.

    “IGFBP-2 was elevated at SCD stage and correlated with plasma tau phosphorylated at threonine 181 and amygdala atrophy.”

    Humansplasman = 287

    Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF-21), and insulin-like growth factor binding protein 2 (IGFBP-2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on IGFBP-2

Fazekas score

upin humans1

1 study
  1. Phosphorylated tau 181 is associated with Fazekas score in humans (cognitively normal) (r=0.165, P=0.015).

    “the plasma p-Tau 181 levels were found to be positively correlated with the Fazekas scores (r=0.165, P=0.015)”

    Humanscognitively normalbrainn = 218

    Neuropathological links between plasma p-Tau 181, white matter hyperintensity, and structural brain changes in aging

    Quantitative imaging in medicine and surgery

More on Fazekas score

Amyloid PET uptake

upin humans1

1 study
  1. Phosphorylated tau 181 is associated with amyloid PET uptake in humans (adjusted for age, sex, and cognitive group) (standardized β=0.19, 95%CI [0.02,0.36], p = .03).

    “Higher amyloid PET uptake was trending with lower plasma Aβ42 (standardized β=‐0.11, 95%CI [‐0.24,0.02], p = .09), and associated with higher pTau181 (standardized β=0.19, 95%CI [0.02,0.36], p = .03)”

    Humansadjusted for age, sex, and cognitive groupplasman = 163

    Correlation Between Plasma Biomarkers Identified in Normal, SCD, and MCI subjects, with PET Amyloid and Tau Neuroimaging

    AAIC 2025 abstract

More on Amyloid PET uptake

Heart rate variability biofeedback

mixedin humans1

1 study
  1. Heart rate variability biofeedback is associated with phosphorylated tau 181 in humans.

    “There were also opposing effects of the Osc+ and Osc- interventions on tTau for younger adults and pTau-181 for older adults.”

    Human trial4 weeksn = 108

    Modulating heart rate oscillation affects plasma amyloid beta and tau levels in younger and older adults

    Scientific reports

More on Heart rate variability biofeedback

All 35

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 48Jan 2026: 11Feb 2026: 3Mar 2026: 4Apr 2026: 8May 2026: 8Jun 2026: 3Jul 2026: 3Aug 2026: 7Sep 2026: 6Oct 2026: 6Nov 2026: 3110 papers in 12 months
medRxiv

Nerve-cell injury marker linked to death risk at ages 92–107

Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.Higher marker levels were linked to higher mortality, with reported hazard ratios (relative death-rate measures) of 1.21 to 1.38 across three cohorts.

Preprint: cohort · 559 peopleBiomarkers
medRxiv

Social isolation linked to blood marker of nerve-cell injury

Persistent severe isolation was linked to higher levels of a blood marker of nerve-cell injury than no isolation, with a statistical association estimate of 0.31.Persistent severe isolation was linked to higher levels of a blood marker of nerve-cell injury than no isolation, with a statistical association estimate of 0.31.

Preprint: cohort study of 3,862 peoplePopulations

See all 212 papers on phosphorylated tau 181